Who Buys Gatifloxacin from India — 93 Importers Behind a $802.0K Market
India's gatifloxacin import market is served by 93 active buyers who collectively imported $802.0K across 240 shipments. SWASTIK PHARMACEUTICALS LTD (UGANDA) leads with a 25.8% market share, followed by HAWKARY PHARMACEUITCAL CO.* and SHAMS AL-THURAYA CO FOR GENERAL TRA. The top 5 buyers together control 62.6% of total import value, reflecting a concentrated buyer landscape.
Gatifloxacin buyer data — 93 importers · $802.0K market · 240 shipmentsTransData Nexus · Indian Customs Data
Top Gatifloxacin Importers — Ranked by Import Value
SWASTIK PHARMACEUTICALS LTD (UGANDA) is the leading gatifloxacin importer from India, holding a 25.8% share of the $802.0K market across 240 shipments from 93 buyers. The top 5 buyers — SWASTIK PHARMACEUTICALS LTD (UGANDA), HAWKARY PHARMACEUITCAL CO.* (IRAQ), SHAMS AL-THURAYA CO FOR GENERAL TRA (IRAQ), GLADPHARM LTD. (UKRAINE), THE LUKE COMMISSION (ESWATINI) — collectively control 62.6% of total import value.
Top Gatifloxacin Buyers & Importers
Ranked by import value · 93 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Gatifloxacin Buyers & Importers — Ranked by Import Value. 93 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Gatifloxacin — and from which countries?
Flow of Gatifloxacin exports from India: each country's share and the named importers behind the numbers
Gatifloxacin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 89.7% of global Gatifloxacin imports — led by Iraq (47.7%) with a total trade value of $802.0K across 240 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Iraq
Iraq emerges as the first largest importing country, achieving a total trade value of $382.5K through 4 shipments. This represents a market share of 47.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Iraq has a diverse importer base, with their top importers including:
• HAWKARY PHARMACEUITCAL CO.* - $101.3K (26.5% of country's total business)
• SHAMS AL-THURAYA CO FOR GENERAL TRA - $92.1K (24.1% of country's total business)
Key Insight: Iraq demonstrates strong market positioning with an average shipment value of $95.6K, indicating premium pricing strategy compared to the market average of $3.3K.
Iraq is a key market for Gatifloxacin imports, representing 47.7% of total trade value.
Primary Market
Secondary Market
2Uganda
Uganda emerges as the second largest importing country, achieving a total trade value of $208.4K through 6 shipments. This represents a market share of 26.0% of the total market activity, demonstrating their significant presence in the industry.
The importation of Gatifloxacin from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like SWASTIK PHARMACEUTICALS LTD in Uganda and HAWKARY PHARMACEUTICAL CO. in Iraq function as intermediaries, procuring Gatifloxacin in bulk for distribution to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as THE LUKE COMMISSION in Eswatini and GLADPHARM LTD. in Ukraine represent hospital networks that import Gatifloxacin directly for in-house use. Their procurement is typically based on patient demand and treatment protocols, leading to periodic, sizable orders aligned with their clinical needs.
Government Procurement Agencies: Entities like the DIRECTORATE OF PROCUREMENT in Myanmar are responsible for national healthcare procurement. They often engage in tender-based purchasing, acquiring large quantities of Gatifloxacin to supply public health facilities. Their buying behavior is influenced by government budgets, public health policies, and disease prevalence, resulting in substantial, scheduled orders.
The importation of Gatifloxacin into the top five importing countries involves specific regulatory processes:
Iraq:
Regulatory Authority: Iraqi Ministry of Health.
Import Registration Process: Importers must obtain approval from the Iraqi Ministry of Health, which includes submitting product dossiers, certificates of analysis, and compliance with local pharmaceutical standards.
Estimated Timeline for Registration: Approximately 6-12 months, depending on the completeness of documentation and regulatory reviews.
Import Tariff/Duty for HS 30049099: Typically ranges from 5% to 10%, subject to changes based on government policies.
Uganda:
Regulatory Authority: National Drug Authority (NDA).
The demand for Gatifloxacin in importing countries is influenced by several factors:
Disease Prevalence: Gatifloxacin is used to treat various bacterial infections, including respiratory tract infections and certain types of tuberculosis. High prevalence rates of these conditions in countries like Iraq and Uganda drive the need for effective antibiotics.
Government Healthcare Programs: National health initiatives aimed at combating infectious diseases often include antibiotics like Gatifloxacin in their treatment protocols. For instance, Uganda's Ministry of Health has programs targeting respiratory infections, necessitating a steady supply of appropriate medications.
Universal Health Coverage Expansion: Efforts to expand healthcare access, particularly in developing nations, increase the demand for essential medicines. As more individuals gain access to healthcare services, the need for antibiotics like Gatifloxacin rises correspondingly.
WHO Essential Medicines List Procurement: While Gatifloxacin is not currently listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions. Countries often align their procurement with WHO recommendations to ensure the availability of critical medications.
Common Questions — Gatifloxacin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest gatifloxacin buyer importing from India?
Based on import volume and value, SWASTIK PHARMACEUTICALS LTD (UGANDA) leads with $206.7K in imports and a 25.8% market share — the highest of any single gatifloxacin importer. HAWKARY PHARMACEUITCAL CO.* (IRAQ) and SHAMS AL-THURAYA CO FOR GENERAL TRA (IRAQ) are the next largest buyers.
QHow many companies buy gatifloxacin from India?
There are 93 active gatifloxacin buyers importing from India, with a combined market of $802.0K across 240 shipments to 46 countries. The top 5 buyers hold 62.6% of total import value, while the remaining 88 buyers handle the other 37.4%.
QWhich countries import the most gatifloxacin from India?
The top importing countries for gatifloxacin from India are Iraq (47.7%), Uganda (26.0%), Ukraine (9.6%), Saudi Arabia (3.4%), Eswatini (3.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of gatifloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for gatifloxacin from India?
The average import transaction value for gatifloxacin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Gatifloxacin from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like SWASTIK PHARMACEUTICALS LTD in Uganda and HAWKARY PHARMACEUTICAL CO. in Iraq function as intermediaries, procuring Gatifloxacin in bulk for distribution to pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as THE LUKE COMMISSION in Eswatini and GLADPHARM LTD. in Ukraine represent hospital networks that import Gatifloxacin directly for in-house use. Their procurement is typically based on patient demand and treatment protocols, leading to periodic, sizable orders aligned with their clinical needs.
Government Procurement Agencies: Entities like the DIRECTORATE OF PROCUREMENT in Myanmar are responsible for national healthcare procurement. They often engage in tender-based purchasing, acquiring large quantities of Gatifloxacin to supply public health facilities. Their buying behavior is influenced by government budgets, public health policies, and disease prevalence, resulting in substantial, scheduled orders.
The importation of Gatifloxacin into the top five importing countries involves specific regulatory processes:
Iraq:
Regulatory Authority: Iraqi Ministry of Health.
Import Registration Process: Importers must obtain approval from the Iraqi Ministry of Health, which includes submitting product dossiers, certificates of analysis, and compliance with local pharmaceutical standards.
Estimated Timeline for Registration: Approximately 6-12 months, depending on the completeness of documentation and regulatory reviews.
Import Tariff/Duty for HS 30049099: Typically ranges from 5% to 10%, subject to changes based on government policies.
Uganda:
Regulatory Authority: National Drug Authority (NDA).
The demand for Gatifloxacin in importing countries is influenced by several factors:
Disease Prevalence: Gatifloxacin is used to treat various bacterial infections, including respiratory tract infections and certain types of tuberculosis. High prevalence rates of these conditions in countries like Iraq and Uganda drive the need for effective antibiotics.
Government Healthcare Programs: National health initiatives aimed at combating infectious diseases often include antibiotics like Gatifloxacin in their treatment protocols. For instance, Uganda's Ministry of Health has programs targeting respiratory infections, necessitating a steady supply of appropriate medications.
Universal Health Coverage Expansion: Efforts to expand healthcare access, particularly in developing nations, increase the demand for essential medicines. As more individuals gain access to healthcare services, the need for antibiotics like Gatifloxacin rises correspondingly.
WHO Essential Medicines List Procurement: While Gatifloxacin is not currently listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions. Countries often align their procurement with WHO recommendations to ensure the availability of critical medications.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Top Importers: Uganda has a diverse importer base, with their top importers including:
• SWASTIK PHARMACEUTICALS LTD - $206.7K (99.2% of country's total business)
Key Insight: Uganda demonstrates strong market positioning with an average shipment value of $34.7K, indicating premium pricing strategy compared to the market average of $3.3K.
Uganda is a key market for Gatifloxacin imports, representing 26.0% of total trade value.
Primary Market
Secondary Market
3Ukraine
Ukraine emerges as the third largest importing country, achieving a total trade value of $77.0K through 2 shipments. This represents a market share of 9.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Ukraine has a diverse importer base, with their top importers including:
• GLADPHARM LTD. - $77.0K (100.0% of country's total business)
Key Insight: Ukraine demonstrates strong market positioning with an average shipment value of $38.5K, indicating premium pricing strategy compared to the market average of $3.3K.
Ukraine is a key market for Gatifloxacin imports, representing 9.6% of total trade value.
Primary Market
Secondary Market
4Saudi Arabia
Saudi Arabia emerges as the fourth largest importing country, achieving a total trade value of $26.9K through 0 shipments. This represents a market share of 3.4% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $26.9K, indicating premium pricing strategy compared to the market average of $3.3K.
Saudi Arabia is a key market for Gatifloxacin imports, representing 3.4% of total trade value.
Primary Market
Secondary Market
5Eswatini
Eswatini emerges as the fifth largest importing country, achieving a total trade value of $24.8K through 5 shipments. This represents a market share of 3.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Eswatini has a diverse importer base, with their top importers including:
• THE LUKE COMMISSION - $24.8K (100.0% of country's total business)
Key Insight: Eswatini demonstrates strong market positioning with an average shipment value of $5.0K, indicating premium pricing strategy compared to the market average of $3.3K.
Eswatini is a key market for Gatifloxacin imports, representing 3.1% of total trade value.
Primary Market
Secondary Market
Retail Chains: Companies such as JAZEERA & GULF CO in Yemen and IC PHARMA LAO CO., LTD in Laos operate pharmacy chains that import Gatifloxacin to stock their outlets. Their procurement is driven by consumer demand, leading to frequent, moderate-sized orders to ensure product availability across their retail locations.
Re-exporters: Some buyers may act as re-exporters, purchasing Gatifloxacin for redistribution to neighboring countries or regions. This segment's purchasing behavior is opportunistic, capitalizing on market demands and trade agreements, resulting in variable order sizes and frequencies.
Contract Manufacturers: Entities like M/S. ENSIGHT PHARMACEUTICALS INC in the Philippines may import Gatifloxacin as an active pharmaceutical ingredient (API) for local formulation and packaging. Their procurement is typically in bulk quantities, aligned with production schedules and market demand forecasts.
Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring efficient supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires submission of a product dossier, including manufacturing licenses, GMP certificates, and product samples.
Estimated Timeline for Registration: Approximately 6-9 months.
Import Tariff/Duty for HS 30049099: Generally around 0% to 5%, with potential exemptions for essential medicines.
Ukraine:
Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control.
Import Registration Process: Involves submission of a comprehensive dossier, including clinical trial data, GMP compliance, and product labeling in Ukrainian.
Estimated Timeline for Registration: Approximately 12-18 months.
Import Tariff/Duty for HS 30049099: Typically around 5%, with possible reductions for essential medicines.
Saudi Arabia:
Regulatory Authority: Saudi Food and Drug Authority (SFDA).
Import Registration Process: Requires submission of product dossiers, GMP certificates, and compliance with SFDA guidelines.
Estimated Timeline for Registration: Approximately 6-12 months.
Import Tariff/Duty for HS 30049099: Generally 5%, with potential exemptions for certain pharmaceuticals.
Import Registration Process: Involves submission of product information, GMP certificates, and adherence to EMRA guidelines.
Estimated Timeline for Registration: Approximately 6-9 months.
Import Tariff/Duty for HS 30049099: Typically around 0% to 5%, with possible exemptions for essential medicines.
Importers should consult the respective regulatory authorities for the most current information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender systems, which can lead to bulk purchasing of antibiotics like Gatifloxacin. This approach ensures cost-effectiveness and consistent supply for public health facilities.
With 93 buyers across 46 countries, the market for Gatifloxacin demonstrates a broad and diverse demand base, presenting opportunities for suppliers to cater to varying healthcare needs globally.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$3.3K
$12.36 per unit
Retail Chains: Companies such as JAZEERA & GULF CO in Yemen and IC PHARMA LAO CO., LTD in Laos operate pharmacy chains that import Gatifloxacin to stock their outlets. Their procurement is driven by consumer demand, leading to frequent, moderate-sized orders to ensure product availability across their retail locations.
Re-exporters: Some buyers may act as re-exporters, purchasing Gatifloxacin for redistribution to neighboring countries or regions. This segment's purchasing behavior is opportunistic, capitalizing on market demands and trade agreements, resulting in variable order sizes and frequencies.
Contract Manufacturers: Entities like M/S. ENSIGHT PHARMACEUTICALS INC in the Philippines may import Gatifloxacin as an active pharmaceutical ingredient (API) for local formulation and packaging. Their procurement is typically in bulk quantities, aligned with production schedules and market demand forecasts.
Understanding these segments is crucial for tailoring marketing strategies, forecasting demand, and ensuring efficient supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Import Registration Process: Requires submission of a product dossier, including manufacturing licenses, GMP certificates, and product samples.
Estimated Timeline for Registration: Approximately 6-9 months.
Import Tariff/Duty for HS 30049099: Generally around 0% to 5%, with potential exemptions for essential medicines.
Ukraine:
Regulatory Authority: State Service of Ukraine on Medicines and Drugs Control.
Import Registration Process: Involves submission of a comprehensive dossier, including clinical trial data, GMP compliance, and product labeling in Ukrainian.
Estimated Timeline for Registration: Approximately 12-18 months.
Import Tariff/Duty for HS 30049099: Typically around 5%, with possible reductions for essential medicines.
Saudi Arabia:
Regulatory Authority: Saudi Food and Drug Authority (SFDA).
Import Registration Process: Requires submission of product dossiers, GMP certificates, and compliance with SFDA guidelines.
Estimated Timeline for Registration: Approximately 6-12 months.
Import Tariff/Duty for HS 30049099: Generally 5%, with potential exemptions for certain pharmaceuticals.
Import Registration Process: Involves submission of product information, GMP certificates, and adherence to EMRA guidelines.
Estimated Timeline for Registration: Approximately 6-9 months.
Import Tariff/Duty for HS 30049099: Typically around 0% to 5%, with possible exemptions for essential medicines.
Importers should consult the respective regulatory authorities for the most current information, as regulations and tariffs are subject to change.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many governments and large healthcare organizations procure medicines through tender systems, which can lead to bulk purchasing of antibiotics like Gatifloxacin. This approach ensures cost-effectiveness and consistent supply for public health facilities.
With 93 buyers across 46 countries, the market for Gatifloxacin demonstrates a broad and diverse demand base, presenting opportunities for suppliers to cater to varying healthcare needs globally.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 93 global importers of Gatifloxacin identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 240 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 46 destination countries with market share per buyer calculated from capped values.
